Agilent Technologies Inc. (Santa Clara, California) has agreed to support research by Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College (New York, New York), into amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Agilent Technologies Inc. (Santa Clara, California) has agreed to support research by Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College (New York, New York), into amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Agilent will provide the latest mass spectrometry technology to support this research, which aims to achieve an understanding of how the most common form of this disease develops in the body.
Gross is an internationally recognized expert in the use of mass spectrometry-based metabolomics. His expertise is in pharmacology and cell biology, particularly in relation to the role of nitric oxide as a signaling molecule. Through the partnership, Agilent will provide two mass spectrometers for Gross’s laboratory.
Sporadic amyotrophic lateral sclerosis (sALS) accounts for about 90 percent of all ALS cases and has no obvious genetic driver. Gross and his collaborators-Giovanni Manfredi, a professor of neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell, and Lorenz Studer, director of Sloan Kettering Institute’s Center for Stem Cell Biology-are investigating the molecular underpinnings of this form of ALS. The Agilent tools will assist the investigators in applying a multi-disciplinary-based approach to understanding the roots of this disease. Specifically, accurate-mass spectrometry will enable the researchers to test the hypothesis that fibroblasts express systemic metabolic markers that inform ALS.
AI and Dual-Sensor Spectroscopy Supercharge Antibiotic Fermentation
June 30th 2025Researchers from Chinese universities have developed an AI-powered platform that combines near-infrared (NIR) and Raman spectroscopy for real-time monitoring and control of antibiotic production, boosting efficiency by over 30%.
Toward a Generalizable Model of Diffuse Reflectance in Particulate Systems
June 30th 2025This tutorial examines the modeling of diffuse reflectance (DR) in complex particulate samples, such as powders and granular solids. Traditional theoretical frameworks like empirical absorbance, Kubelka-Munk, radiative transfer theory (RTT), and the Hapke model are presented in standard and matrix notation where applicable. Their advantages and limitations are highlighted, particularly for heterogeneous particle size distributions and real-world variations in the optical properties of particulate samples. Hybrid and emerging computational strategies, including Monte Carlo methods, full-wave numerical solvers, and machine learning (ML) models, are evaluated for their potential to produce more generalizable prediction models.